Amin Makarem

Stock Analyst at Jefferies

(1.80)
# 3,220
Out of 4,429 analysts
2
Total ratings
50%
Success rate
16.4%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Amin Makarem

UroGen Pharma
Apr 9, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $34.99
Upside: +14.32%
Foghorn Therapeutics
Feb 16, 2026
Maintained: Buy
Price Target: $12
Current: $4.18
Upside: +187.08%